Camfil Opakfil ES energy-saving filters
01 March, 2021 | Supplied by: Camfil Australia Pty LtdCamfil Opakfil ES filters remove airborne contaminants such as smoke, bacteria, fumes, fungi and virus-bearing droplet nuclei.
Childhood dementia: spotlight on a rare disease
26 February, 2021Following Rare Diseases Day, we shine a spotlight on childhood dementia, which affects 2300 children in Australia.
Australia's COVID-19 vaccine rollout commences
23 February, 2021Australia's vaccine program kicked off at the start of this week, with the country's most vulnerable community members first off the block to receive the Pfizer–BioNTech vaccine.
Medicinal cannabis course launched for Australian GPs
23 February, 2021The online Professional Diploma of Medicinal Cannabis aims to provide a best-practice roadmap for GPs on how to manage common conditions with medicinal cannabis.
DiDi supports vaccine rollout via free trips for frontline workers
19 February, 2021Rideshare service DiDi has launched a new service — DiDi Vaccinate — which will provide free trips to frontline workers to assist in the rollout of the COVID-19 vaccine in Australia.
St John Ambulance launches defibrillators to boost bystander rescues
17 February, 2021St John Ambulance has launched two groundbreaking defibrillators to improve bystander participation during sudden cardiac arrest emergencies.
Skeletal age calculator predicts fracture risk
16 February, 2021Researchers have developed a model that predicts the biological age of bones, estimating an individual's risk of bone fracture and premature death.
Partnership delivers smart, reusable PPE solutions
15 February, 2021RFiD Discovery and Welspring have partnered to offer high-quality, reusable and trackable protective garments for frontline healthcare workers.
Long-lasting infection-control solution now available in Australia
12 February, 2021SurfaceWise2, a hospital-grade disinfectant that makes surfaces hostile to germs for up to three months, has been launched in Australia by Allied BioServices.
Vaccine rollout may face delays
11 February, 2021 by Amy SarcevicInsufficient manufacturing infrastructure and incorrect handling after dispatch are creating supply shortfalls and wastage around the world.
Russian Sputnik vaccine demonstrates 91.6% efficacy
08 February, 2021Preliminary results from the Russian COVID-19 phase 3 vaccine trial suggest that the two-dose vaccine regimen is 91.6% efficacious against symptomatic COVID-19.
Aus biotech company supplies at-home COVID-19 tests to US
05 February, 2021 by Lauren DavisQueensland-based company Ellume has announced a US$231.8 million (AU$302.7 million) agreement to accelerate domestic US production of its COVID-19 home tests.
Active ingredient prescribing comes into effect
04 February, 2021 by Matthew Grant, Monash UniversityDoctors must now prescribe drugs using their chemical name, not brand names. That's good news for patients.
Novavax vaccine demonstrates 89.3% efficacy
03 February, 2021Novavax has announced that its protein-based COVID-19 vaccine candidate has demonstrated a vaccine efficacy of 89.3% in a Phase 3 clinical trial conducted in the UK.
Blood cancer burden on the rise
03 February, 2021Blood cancers are now the second most diagnosed cancers in Australia and the second most common cause of cancer-related deaths, according to the Leukaemia Foundation.
